New England Journal of Medicine Report

Diethylstilbestrol in utero exposure and cancers risk, 2011

From Maryland – Exposure to Diethylstilbestrol in the womb raises a woman’s risk of many cancers, according to a report published in the New England Journal of Medicine. Researchers studied over 6500 women, 4600 of whom were exposed to DES in the womb. Results showed that this exposure significantly increased risk of many cancers and fertility problems, including a 40x increased risk of clear-cell adenocarcinoma, 8x increased risk of neonatal death, 2.4x increased risk of infertility and a 1.8x increased risk of breast cancer.

Video from Insidermedicine In 60.

Watch our compilation of DES Videos in English on YouTube via the Diethylstilboestrol Channel.

More DES DiEthylStilbestrol Resources

Beating Cancer One Lap at a Time

DES Daughter Susan Helmrich is one of the best swimmers in the world in her age group

Susan Helmrich is one of the best swimmers in the world in her age group. She’s also a three-time cancer survivor and a victim of one of the greatest drug tragedies in history. With luck, determination, great medical care, the support of family and friends and the benefits of the sport of swimming, Susan has fought to escape the deadly legacy of a supposed wonder drug turned nightmare.

Links
More DES DiEthylStilbestrol Resources

The DES Generations Concern

Diethylstilbestrol DES has consequences for those who took it, their children and maybe their grandchildren

Meet Caitlin McCarthy, a multi-award winning writer and DES Daughter. Diethylstilbestrol DES has consequences for those who took it, their children and maybe their grandchildren.

More DES DiEthylStilbestrol Resources

DES and Breast Cancer

A breast cancer survivor, Jackie, reports on her DES journey

Jackie White is one of 53 women who is bringing the DES Breast Cancer lawsuit in Boston against the maker of the drug DES (diethylstilbestrol) prescribed to millions of women decades ago.

According to a large study, DES, the anti-miscarriage drug used in the USA until 1971 but also used in Australia and many European countries well after 1971, has been linked to health problems — including breast cancer, infertility, difficult pregnancies and early menopause — in the daughters and the granddaughters of women who took it.

The study suggests that one in 50 DES daughters had the chance of developing breast cancer due to their DES exposure.
Read more about DES and breast cancer risks.

More DES DiEthylStilbestrol Resources

The DES Paper 40th Anniversary – Dr Arthur Herbst

The University of Chicago, 17 May 2011

Commemorating Arthur L Herbst and the 40th Anniversary of His Landmark DES Paper.

More DES DiEthylStilbestrol Resources

The DES Story, Lessons Learned

National Cancer Institute, October 2011

Dr. Robert Hoover, director of NCI’s Epidemiology and Biostatistics Programme, discusses a new study of diethylstilbestrol (DES), a drug once prescribed to pregnant women. Dr. Hoover describes the history behind DES and the long-term health effects that are now known to be associated with prenatal exposure to the drug. A written article about the study appears in the NCI DES follow-up study.

More DES DiEthylStilbestrol Resources